UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

~~Washington~~WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER ~~PURSUANT TO RULE 13a-16~~

~~OR 15d-16~~PURSUANT ~~UNDER~~TO ~~THE~~RULE ~~SECURITIES~~13a-16 ~~EXCHANGE~~OR ~~ACT OF 1934~~ 15d-16

~~For the~~UNDER ~~month~~THE ofSECURITIES ~~August~~EXCHANGE ~~2025~~ACT OF 1934

For the month of March 2026

Commission File Number: 001-42728

Masonglory Limited

(Registrant’s Name)

Room 8, 25/F, CRE Centre

889 Cheung Sha Wan

Kowloon, Hong Kong

(Address of ~~principal~~Principal ~~executive~~Executive ~~office~~Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.:

Form 20-F ☒ Form 40-F ☐

When used in this Form 6-K, unless otherwise indicated, the terms “the Company,” “Masonglory,” “we,” “us” and “our” refer to Masonglory Limited and its subsidiaries.

~~Appointment of~~Nasdaq ~~Director~~Notification Regarding Minimum Bid Price Deficiency

On ~~August~~ 29March 13, ~~2025~~2026, ~~the~~Masonglory ~~board~~Limited of(“Company”) received ~~directors~~a letter (the “~~Board~~Nasdaq Letter”) offrom ~~Masonglory~~the ~~Limited~~staff ~~(the~~at Nasdaq Stock Market LLC (“~~Company~~Nasdaq”) ~~approved~~notifying the ~~appointment~~Company ofthat ~~Ms.~~it ~~Xie~~is ~~Jinyu~~not ~~(Ms.~~in ~~Xie)~~compliance aswith the requirement to maintain a ~~director~~minimum closing bid price of ~~the~~$1 ~~Company~~per share, ~~effective~~as ~~August~~set ~~29,~~forth ~~2025.~~in ~~Pursuant~~Nasdaq toListing Rule ~~the~~5550(a)(2), ~~director~~because ~~agreement~~the ~~between~~closing ~~Ms.~~bid ~~Xie and~~price of the Company,’s ~~Ms.~~ordinary ~~Xie~~shares ~~shall~~was ~~hold~~below ~~such~~$1 ~~office~~per ~~until~~share for the ~~director’s~~last ~~earlier~~30 ~~death~~consecutive business days (i.e. from January 28, ~~disqualification~~2026 to March 11, ~~resignation~~2026). orThe ~~removal~~Nasdaq ~~from office~~Letter inis ~~accordance~~only ~~with~~a ~~the~~notification ~~director~~of ~~agreement,~~deficiency. It does not result in the ~~amended~~immediate delisting and ~~restated~~has ~~memorandum~~no ~~and~~current ~~the~~effect ~~amended~~on ~~and~~the ~~restated~~listing ~~articles~~or oftrading ~~association~~ of the Company,’s orordinary ~~any~~shares ~~applicable~~on ~~laws,~~the ~~rules,~~Nasdaq orCapital Market ~~regulations~~at this time.

~~The~~In accordance with Nasdaq Listing Rule 5810(c)(3)(A), ~~biographical~~the ~~information~~ Company has 180 calendar days, or until September 9, 2026 (the “Compliance Period”), to regain compliance with the minimum bid price requirement. To regain compliance with the minimum bid price requirement, the closing bid price of Ms the Company’s ordinary shares must be at least $1.00 ~~Xie~~per isshare ~~set~~for ~~forth~~a ~~below~~minimum of 10 consecutive business days at any time prior to the expiration of Compliance Period. If the Company regains compliance with the minimum bid price requirement within the Compliance Period, Nasdaq will provide the Company with written confirmation and will close the matter. If the Company chooses to implement a reverse stock split, it must complete the split no later than ten business days prior to September 9, 2026 in order to regain compliance.

~~Ms.~~If the Company does not regain compliance by September ~~Xie~~9, ~~Jinyu~~2026, ~~has~~the ~~over~~Company 16may ~~years~~be ofeligible ~~experience~~for inan ~~accounting~~additional ~~and~~180 ~~investment.~~calendar Msday compliance period. ~~Xie~~To ~~currently~~qualify, ~~serves~~the asCompany anwill ~~accountant~~be atrequired ~~Zhuhai~~to ~~Wushui~~meet ~~Investment~~the ~~Holding~~continued ~~Co.~~listing requirement for market value of publicly held shares and all other initial listing standards for the Nasdaq Capital Market, ~~Ltd.~~with the exception of the bid price requirement, aand ~~position~~will ~~she~~need ~~has~~to ~~held~~provide ~~since~~written ~~2017.~~notice ~~From~~of ~~2012~~its intention to ~~2017~~cure the deficiency during the second compliance period, ~~she~~by ~~was~~effecting ~~engaged~~a inreverse ~~self-directed~~stock ~~investment~~split, if necessary. If the Company meets these requirements, ~~activities~~Nasdaq will inform the Company that it has been granted an additional 180 calendar days. ~~Prior~~However, if it appears to Nasdaq that, ~~Ms.~~the ~~Xie~~Company will ~~has~~not ~~also~~be ~~held~~able to cure the ~~position~~deficiency, ofor ~~accountant~~if atthe ~~AEON~~Company ~~South~~is ~~China~~otherwise ~~Commercial~~not ~~Co.~~eligible, ~~Ltd.,~~Nasdaq ~~from~~will ~~2009~~provide notice that its securities will be subject to ~~2012~~delisting.

~~Ms. Xie~~The ~~holds~~Company anis ~~associate~~monitoring ~~degree~~the inclosing ~~financial~~bid ~~management~~price of ~~from~~its ~~Guangdong~~ordinary ~~Peizheng~~shares ~~College~~and inevaluating options to regain compliance with the ~~PRC~~minimum inbid ~~2006~~price ~~and~~requirement, ~~obtained~~including by effecting a ~~certificate~~reverse stock ofsplit, if necessary. However, there can be no assurance that the Company will be able to timely regain or maintain compliance with ~~accounting~~Nasdaq’s ~~professional~~continued inlisting ~~2009~~requirement.

~~Ms. Xie~~The ~~has no family relationships with any of the executive officers or directors of the~~ Company. ~~There~~issued ~~has~~a ~~been~~press norelease ~~transactions~~on inthis ~~the~~development, ~~past~~a ~~two~~copy ~~years~~of to which ~~the Company or any of its subsidiaries was or~~ is toattached behereto aas ~~party,~~Exhibit ~~in which Ms~~99.1 ~~Xie~~and ~~had,~~is orincorporated ~~will~~herein ~~have,~~by ~~a direct or indirect material interest~~reference.

Financial Statements and Exhibits.

Exhibit No.		Description
99.1		Press Release dated March 17, 2026 - Masonglory Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

~~SIGNATURE~~SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Masonglory Limited By: /s/ Tse Shing Fung Name: Tse Shing Fung Title: Chairman of the Board and Director

	Masonglory Limited

Date: March 17, 2026	By:	/s/ Tse Shing Fung
	Name:	Tse Shing Fung
	Title:	Chairman of the Board and Director

Date: August 29, 2025

Filing Compare · Masonglory Ltd